Physician profile

Samira Polina Queen

Gerontology (Nurse Practitioner) · Tulsa, OK

NPI 1871081703

$3,197.02

in general payments reported to CMS, 2019-2025

32 companies · $634 in 2025

The $634 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).

See the full distribution for Gerontology (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,903.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $602.86 2021-2025 Endurant Iis
W. L. Gore & Associates, INC. $267.53 2021-2023 Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis
Novo Nordisk INC $244.48 2022-2025 Wegovy, Ozempic, Rybelsus
Abiomed $238.17 2023-2025 Impella
Atricure, INC. $208.00 2021-2025 Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System
Bolton Medical INC $195.11 2023-2025 Treo Abdominal Stent-Graft System, Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $185.06 2021-2025 Lifevest
Janssen Pharmaceuticals, INC $172.71 2022-2024 Xarelto
Chiesi USA, INC. $154.39 2021-2025 Cleviprex, Kengreal
Baxter Healthcare $139.03 2022-2024 Preveleak
Becton, Dickinson and Company $112.66 2021-2025
Nuwellis, INC. $85.76 2021-2024 Aquadex Smartflow Console
Polynovo North America LLC $63.45 2022-2024 Novosorb Btm
Medline Industries LP $53.53 2023
Solventum Corporation $53.33 2024-2025 Prevena, Spoton, V.A.C. Veraflo Cleanse Choice
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Getinge USA Sales, LLC $42.05 2021-2023 Flixene
Ethicon US, LLC $40.09 2025 Prolene
Silk Road Medical, INC. $35.78 2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Endologix LLC $31.17 2025 Endocross Device, Torus Stent Graft System
Edwards Lifesciences Corporation $30.95 2021
Kci USA, INC. $30.93 2021-2022
Acera Surgical, INC. $28.56 2025 Restrata Wound Matrix
Pacira Pharmaceuticals Incorporated $24.80 2021
Cvrx, INC. $20.61 2024 Barostim Neo System
Teleflex LLC $20.01 2021
Grifols USA, LLC $19.41 2023 Thrombate III
Viz.Ai, INC. $18.99 2022
Convatec INC. $18.46 2022
Depuy Synthes Sales INC. $16.18 2025 Terazol 3
Astrazeneca Pharmaceuticals LP $15.40 2022
Surmodics, INC. $14.33 2023 Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter
Cagent Vascular INC $13.23 2025 Serrantor

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Samira Polina Queen

$3,197.02

in general payments reported 2019-2025

Years
2021-2025
Top company
Medtronic, INC.
Context
The $634 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).

https://glasscript.com/doctor/10936978/samira-polina-queen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.